Covid nasal spray moves to Phase 2 study
Encouraging preliminary results from an ongoing phase 1 study have triggered the announcement of phase 2 studies for a first-in-class nasal spray to
New South Wales Mike Calford Nathan Bartlett Hunter Medical Research Institute Hunter New England Health Ppd Inc
Source: miragenews.com